在小鼠喘模型中,电子烟通过细胞因子诱导和MUC5AC/5B表达加剧过敏炎症
Young-Ha Lee1, Hyung Gyun Na1, Yoon Seok Choi1
1Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Yeungnam University, Daegu, Republic of Korea.
Environmental toxicology and pharmacology
|February 21, 2024
概括
电子烟 (电子烟) 蒸汽暴露在喘模型中加剧了过敏炎症和呼吸道过敏反应. 在喘患者中使用电子烟可能会增加粘液的产生,加剧喘症状.
科学领域:
- 肺部医学 肺部医学
- 毒理学 毒理学 毒理学
- 免疫学 免疫学 免疫学
背景情况:
- 喘是一种慢性呼吸道疾病,其特点是气道炎症和过度反应.
- 电子烟 (e-cigarette) 蒸汽对喘恶化的影响尚不清楚.
- 电子烟的使用量在全球范围内不断增加,需要对其呼吸系统健康影响进行研究.
研究的目的:
- 为了研究电子烟蒸汽对过敏呼吸道炎症的影响.
- 在小鼠喘模型中评估电子烟暴露对细胞因子产生和粘素表达的影响.
- 为了确定电子烟是否会加剧类似喘的症状.
主要方法:
- 通过卵蛋白 (OVA) 敏感化建立了一种小鼠喘模型.
- 鼠标被暴露在电子烟蒸汽,OVA或两者之间.
- 测量了气道过敏反应,炎症细胞透,Th2细胞因子水平 (互白素-4和-5) 和粘素 (MUC5AC和MUC5B) 表达.
主要成果:
- 与对照组相比,在对OVA敏感的小鼠中,电子烟暴露显著增加了呼吸道过敏反应.
- 在暴露于电子烟的OVA组中观察到更大的炎症细胞透和升高的Th2细胞因子 (中白素-4和-5).
- 在暴露于电子烟蒸汽和OVA的小鼠中,MUC5AC和MUC5B粘素水平显著升高,表明粘液产量增加.
结论:
- 暴露于电子烟蒸汽会在小鼠喘模型中加剧过敏呼吸道炎症和高反应性.
- 患有喘的人使用电子烟可能会导致粘素分泌量增加,可能会使病情恶化.
- 这些发现凸显了喘患者使用电子烟的风险,需要进一步调查.
关键词:
喘 喘 是一种电子烟是一种电子烟.IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-4-IL-IL-4-IL-4-IL-4-IL-4-IL-4-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-IL-4 is is is is is is is what you are is what you are is what you are在IL-5中,IL-5是最常见的.在 MUC5ACAC 中.在MUC5B中,MUC5B是MUC5B.
相关概念视频
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:20Asthma: Pathogenesis and Management
398
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
297
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
297
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
247
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
247